Technical University of Braunschweig

First Published Articles of APL Quantum Now Live

Retrieved on: 
Mercoledì, Febbraio 28, 2024

MELVILLE, N.Y., Feb. 28, 2024 /PRNewswire/ -- AIP Publishing is thrilled to announce the first published articles of APL Quantum , its latest open access journal.

Key Points: 
  • MELVILLE, N.Y., Feb. 28, 2024 /PRNewswire/ -- AIP Publishing is thrilled to announce the first published articles of APL Quantum , its latest open access journal.
  • APL Quantum publishes the latest and most innovative research across all of quantum science, including but not limited to fundamentals, phenomena, resources, applied science, and technologies.
  • APL Quantum's first articles serve as a strong example of the new journal's impressive scope, featuring articles on quantum materials, the modeling of quantum fluctuations and establishment and use of quantum technologies, and the conception of a programmable photonic quantum emulator.
  • "The first issue of APL Quantum is an exciting and pivotal moment for AIP Publishing and the broader research community," said Dr. Penelope Lewis, AIP Publishing's Chief Publishing Officer.

Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

Retrieved on: 
Venerdì, Settembre 1, 2023

LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.

Key Points: 
  • LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.
  • Dr. Kaufmann joins Hansa from Pieris Pharmaceuticals where he has served as Chief Scientific Officer since 2019.
  • Søren Tulstrup, President and CEO, Hansa Biopharma said, "We are thrilled to welcome Hitto to Hansa at this pivotal time.
  • Dr. Hitto Kaufmann has served as Chief Scientific Officer at Pieris Pharmaceuticals since 2019.

Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

Retrieved on: 
Venerdì, Settembre 1, 2023

LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.

Key Points: 
  • LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.
  • Dr. Kaufmann joins Hansa from Pieris Pharmaceuticals where he has served as Chief Scientific Officer since 2019.
  • Søren Tulstrup, President and CEO, Hansa Biopharma said, "We are thrilled to welcome Hitto to Hansa at this pivotal time.
  • Dr. Hitto Kaufmann has served as Chief Scientific Officer at Pieris Pharmaceuticals since 2019.

Enevate Appoints EV Battery Veteran Janis Doelle as VP, Sales and Marketing

Retrieved on: 
Martedì, Giugno 6, 2023

Enevate, a pioneering battery innovation company featuring fast charge and high-density battery technologies for electric vehicles (EVs) and other markets, announced the appointment of EV battery veteran, Janis Doelle, to Vice President, Sales and Marketing.

Key Points: 
  • Enevate, a pioneering battery innovation company featuring fast charge and high-density battery technologies for electric vehicles (EVs) and other markets, announced the appointment of EV battery veteran, Janis Doelle, to Vice President, Sales and Marketing.
  • “Janis brings more than 15 years of impressive, results-oriented experience in the battery industry with particular focus on converting R&D projects to commercial-scale production at several of the world’s leading automotive and battery companies,” said Enevate CEO Bob Kruse.
  • He later moved to Samsung SDI’s Marketing and Product Planning Department where he served as a senior manager for technical marketing, business development, product planning and program management for major EV OEM battery projects.
  • In that role, he headed development of new battery cell designs and chemistry platforms for major EV OEM customers.

Expitope 3.0 presented at CIMT enables more comprehensive analysis of target antigens and increases accuracy of safety assessment

Retrieved on: 
Giovedì, Maggio 4, 2023

Through this joint endeavor, deep academic expertise in sophisticated bioinformatics, is applied for in silico assessment of potential target antigens for T cell receptor engineered T cell (TCR-T) therapies  for treatment of solid cancer.

Key Points: 
  • Through this joint endeavor, deep academic expertise in sophisticated bioinformatics, is applied for in silico assessment of potential target antigens for T cell receptor engineered T cell (TCR-T) therapies  for treatment of solid cancer.
  • Comparing pHLA epitope expression in various healthy tissues allows to predict potential cross-reactivity and off-target toxicity thereby minimizing safety risks.
  • In summary, Expitope 3.0 allows for a quicker analysis with a broader search of databases and higher prediction accuracy of pHLA epitopes in antigens.
  • We are pleased that this long standing collaboration allowed this updated webtool to be developed to better meet these needs.”

SATOSHI TESHIMA JOINS AC MARTIN AS ARCHITECTURAL DESIGN PRINCIPAL

Retrieved on: 
Mercoledì, Dicembre 21, 2022

LOS ANGELES, Dec. 21, 2022 /PRNewswire/ -- Satoshi Teshima, AIA, LEED AP BD+C, joined AC Martin, Inc. in October as a Design Principal.

Key Points: 
  • LOS ANGELES, Dec. 21, 2022 /PRNewswire/ -- Satoshi Teshima, AIA, LEED AP BD+C, joined AC Martin, Inc. in October as a Design Principal.
  • "We are excited to welcome Satoshi to our AC Martin Team."
  • "His design skills, teaming style, and emotional intelligence will elevate our communication and design solutions for our Higher Education projects. "
  • Prior to joining AC Martin, Satoshi held design leadership positions at HGA and HDR.

EQS-News: Clean Logistics SE: Lower Saxony's Environmental Minister, Olaf Lies, presents Clean Logistics SE with a grant notification in the amount of around EUR 7.6 million for a planned development project

Retrieved on: 
Venerdì, Ottobre 28, 2022

Hamburg, 26 October 2022: Clean Logistics SE (ISIN DE000A1YDAZ7) receives as a first building block for a development project planned for the years 2023 to 2025 a grant from the State of Lower Saxony.

Key Points: 
  • Hamburg, 26 October 2022: Clean Logistics SE (ISIN DE000A1YDAZ7) receives as a first building block for a development project planned for the years 2023 to 2025 a grant from the State of Lower Saxony.
  • EUR 5.5 million of the total amount of around EUR 7.6 million will be awarded to XPANSE, around EUR 1.6 million to CLT and approx.
  • By continuously upgrading its product portfolio, Clean Logistics SE sustainably strengthens the marketability of its innovative, safe and durable solutions.
  • Clean Logistics SE includes in addition to the Dutch truck manufacturer GINAF Trucks Nederland B.V., the subsidiaries E-Cap Mobility GmbH, XPANSE Powertrain GmbH and Clean Logistics Technology GmbH.

NXP and German Aerospace Center DLR Collaborate on Quantum Computing Technologies in Germany

Retrieved on: 
Giovedì, Ottobre 27, 2022

NXPs contributions include the hardware components required for integrating quantum computers in classical computing environments, photon detection sensor technology and packaging

Key Points: 
  • NXPs contributions include the hardware components required for integrating quantum computers in classical computing environments, photon detection sensor technology and packaging
    The DLR Innovation Center is located at the NXP site in Hamburg, Germany
    HAMBURG, Germany, Oct. 27, 2022 (GLOBE NEWSWIRE) -- NXP Semiconductors (NASDAQ: NXPI)today announced its collaboration with the German Aerospace Center (DLR) and other partners on ion trap-based quantum computers as part of the DLRs Quantum Computing Initiative.
  • To help achieve these new innovations, NXP is collaborating with recognized leaders in the field of quantum computing.
  • DLR is awarding contracts as part of its Quantum Computing Initiative, with the aim of creating qubits based on ion traps.
  • As the first German quantum computer manufacturer, eleQtron currently builds increasingly powerful quantum computers and connects them to the cloud.